168 related articles for article (PubMed ID: 33092755)
1. Impact of Nonalcoholic Fatty Liver Disease on Arrhythmia Recurrence Following Atrial Fibrillation Ablation.
Donnellan E; Cotter TG; Wazni OM; Elshazly MB; Kochar A; Wilner B; Patel D; Kanj M; Hussein A; Baranowski B; Cantillon D; Griffin B; Jaber W; Saliba WI
JACC Clin Electrophysiol; 2020 Oct; 6(10):1278-1287. PubMed ID: 33092755
[TBL] [Abstract][Full Text] [Related]
2. Impact of risk-factor modification on arrhythmia recurrence among morbidly obese patients undergoing atrial fibrillation ablation.
Donnellan E; Wazni OM; Kanj M; Elshazly M; Hussein AA; Patel DR; Trulock K; Wilner B; Baranowski B; Cantillon DJ; Varma N; Jaber W; Saliba WI
J Cardiovasc Electrophysiol; 2020 Aug; 31(8):1979-1986. PubMed ID: 32510749
[TBL] [Abstract][Full Text] [Related]
3. Interatrial septal fat thickness and left atrial stiffness are mechanistic links between nonalcoholic fatty liver disease and incident atrial fibrillation.
Mahfouz RA; Gouda M; Galal I; Ghareb MS
Echocardiography; 2019 Feb; 36(2):249-256. PubMed ID: 30548700
[TBL] [Abstract][Full Text] [Related]
4. Association between pre-ablation bariatric surgery and atrial fibrillation recurrence in morbidly obese patients undergoing atrial fibrillation ablation.
Donnellan E; Wazni OM; Kanj M; Baranowski B; Cremer P; Harb S; McCarthy CP; McEvoy JW; Elshazly MB; Aagaard P; Tarakji KG; Jaber WA; Schauer PR; Saliba WI
Europace; 2019 Oct; 21(10):1476-1483. PubMed ID: 31304532
[TBL] [Abstract][Full Text] [Related]
5. Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success.
Schreiber D; Rostock T; Fröhlich M; Sultan A; Servatius H; Hoffmann BA; Lüker J; Berner I; Schäffer B; Wegscheider K; Lezius S; Willems S; Steven D
Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):308-17. PubMed ID: 25744570
[TBL] [Abstract][Full Text] [Related]
6. The association of non-alcoholic fatty liver disease and atrial fibrillation: a review.
Käräjämäki AJ; Hukkanen J; Ukkola O
Ann Med; 2018 Aug; 50(5):371-380. PubMed ID: 29929399
[TBL] [Abstract][Full Text] [Related]
7. Sex-related risks of recurrence of atrial fibrillation after ablation: Insights from the Guangzhou Atrial Fibrillation Ablation Registry.
Deng H; Shantsila A; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Liu Y; Wei W; Fu L; Xue Y; Wu S; Lip GYH
Arch Cardiovasc Dis; 2019 Mar; 112(3):171-179. PubMed ID: 30683618
[TBL] [Abstract][Full Text] [Related]
8. Genetic Susceptibility for Atrial Fibrillation in Patients Undergoing Atrial Fibrillation Ablation.
Shoemaker MB; Husser D; Roselli C; Al Jazairi M; Chrispin J; Kühne M; Neumann B; Knight S; Sun H; Mohanty S; Shaffer C; Thériault S; Rinke LL; Siland JE; Crawford DM; Ueberham L; Zardkoohi O; Büttner P; Geelhoed B; Blum S; Aeschbacher S; Smith JD; Van Wagoner DR; Freudling R; Müller-Nurasyid M; Montgomery J; Yoneda Z; Wells Q; Issa T; Weeke P; Jacobs V; Van Gelder IC; Hindricks G; Barnard J; Calkins H; Darbar D; Michaud G; Kääb S; Ellinor P; Natale A; Chung M; Nazarian S; Cutler MJ; Sinner MF; Conen D; Rienstra M; Bollmann A; Roden DM; Lubitz S
Circ Arrhythm Electrophysiol; 2020 Mar; 13(3):e007676. PubMed ID: 32078373
[TBL] [Abstract][Full Text] [Related]
9. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.
Black-Maier E; Ren X; Steinberg BA; Green CL; Barnett AS; Rosa NS; Al-Khatib SM; Atwater BD; Daubert JP; Frazier-Mills C; Grant AO; Hegland DD; Jackson KP; Jackson LR; Koontz JI; Lewis RK; Sun AY; Thomas KL; Bahnson TD; Piccini JP
Heart Rhythm; 2018 May; 15(5):651-657. PubMed ID: 29222043
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes.
Targher G; Mantovani A; Pichiri I; Rigolon R; Dauriz M; Zoppini G; Morani G; Vassanelli C; Bonora E
Clin Sci (Lond); 2013 Sep; 125(6):301-9. PubMed ID: 23596966
[TBL] [Abstract][Full Text] [Related]
11. Impact of a nurse-led limited risk factor modification program on arrhythmia outcomes in patients with atrial fibrillation undergoing catheter ablation.
Yaeger A; Keenan BT; Cash NR; Parham T; Deo R; Frankel DS; Schaller RD; Santangeli P; Nazarian S; Supple GE; Arkles J; Kumareswaran R; Hyman MC; Riley MP; Garcia FC; Lin D; Epstein AE; Callans DJ; Mora JI; Amaro A; Schwab R; Pack A; Marchlinski FE; Dixit S
J Cardiovasc Electrophysiol; 2020 Feb; 31(2):423-431. PubMed ID: 31916273
[TBL] [Abstract][Full Text] [Related]
12. Impact of advanced liver fibrosis on atrial fibrillation recurrence after ablation in non-alcoholic fatty liver disease patients.
Wang Z; Wang Y; Luo F; Zhai Y; Li J; Chen Y; Li Q; Zhu L; Jiao S; Liu P; Zhou Y; Chen Y; Dong J; Sun Y
Front Cardiovasc Med; 2022; 9():960259. PubMed ID: 36277780
[TBL] [Abstract][Full Text] [Related]
13. Attenuated heart rate recovery is associated with higher arrhythmia recurrence and mortality following atrial fibrillation ablation.
Donnellan E; Wazni OM; Chung MK; Elshazly MB; Chung R; Taigen T; Niebauer M; Kochar A; Hussain M; Patel DR; Il'Giovine Z; Harb S; Cantillon DJ; Kanj M; Saliba W; Jaber W
Europace; 2021 Jul; 23(7):1063-1071. PubMed ID: 33463688
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Atrial Fibrillation Ablation in Morbidly Obese Patients Following Bariatric Surgery Compared With a Nonobese Cohort.
Donnellan E; Wazni O; Kanj M; Hussein A; Baranowski B; Lindsay B; Aminian A; Jaber W; Schauer P; Saliba W
Circ Arrhythm Electrophysiol; 2019 Oct; 12(10):e007598. PubMed ID: 31610693
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease is associated with increased risk of atrial fibrillation.
Cai X; Zheng S; Liu Y; Zhang Y; Lu J; Huang Y
Liver Int; 2020 Jul; 40(7):1594-1600. PubMed ID: 32279432
[TBL] [Abstract][Full Text] [Related]
16. Conventional versus 3-D Echocardiography to Predict Arrhythmia Recurrence After Atrial Fibrillation Ablation.
Bossard M; Knecht S; Aeschbacher S; Buechel RR; Hochgruber T; Zimmermann AJ; Kessel-Schaefer A; Stephan FP; Völlmin G; Pradella M; Sticherling C; Osswald S; Kaufmann BA; Conen D; Kühne M
J Cardiovasc Electrophysiol; 2017 Jun; 28(6):651-658. PubMed ID: 28301685
[TBL] [Abstract][Full Text] [Related]
17. Family history of atrial fibrillation as a predictor of atrial substrate and arrhythmia recurrence in patients undergoing atrial fibrillation catheter ablation.
Kapur S; Kumar S; John RM; Stevenson WG; Tedrow UB; Koplan BA; Epstein LM; MacRae CA; Michaud GF
Europace; 2018 Jun; 20(6):921-928. PubMed ID: 28541417
[TBL] [Abstract][Full Text] [Related]
18. Association between Atrial Fibrillation and Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
Kang MK; Park JG; Kim MC
Yonsei Med J; 2020 Oct; 61(10):860-867. PubMed ID: 32975060
[TBL] [Abstract][Full Text] [Related]
19. Impact of left atrial box surface ratio on the recurrence after ablation for persistent atrial fibrillation.
Keçe F; Scholte AJ; de Riva M; Naruse Y; Watanabe M; Alizadeh Dehnavi R; Schalij MJ; Zeppenfeld K; Trines SA
Pacing Clin Electrophysiol; 2019 Feb; 42(2):208-215. PubMed ID: 30520059
[TBL] [Abstract][Full Text] [Related]
20. A U-shaped relationship of body mass index on atrial fibrillation recurrence post ablation: A report from the Guangzhou atrial fibrillation ablation registry.
Deng H; Shantsila A; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Liu Y; Wei W; Fu L; Wu S; Xue Y; Lip GYH
EBioMedicine; 2018 Sep; 35():40-45. PubMed ID: 30174278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
